Roivant Sciences Ltd. ROIV | NASDAQ

$11.66 $0.08 | 0.65%

Next Earnings: May 28, 2025

Company Overview:

Market Cap: $8.32B
PE Ratio: -11.65
52-Week Range: $8.73 - $13.06

4.4 Year Performance Metrics:

Total Return (with DRIP): 11.35% (2.47% / yr)
Total Return (no DRIP): 11.35% (2.47% / yr)
Share Price: 11.35%
ROIV Total Return
1Y 2Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

ROIV Earnings, Revenue, Cash & Debt, Shares Outstaning:

ROIV - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
ROIV - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ROIV - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
ROIV - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
ROIV - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
ROIV - Cash & Debt
14-Day FREE Trial Get Full Access Now!
ROIV - Revenue
14-Day FREE Trial Get Full Access Now!
ROIV Revenue CAGR:1Y: -75.72%2Y: -27.28%5Y: 0.00%10Y: 0.00%
ROIV - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
ROIV EPS CAGR:1Y: -96.19%2Y: 55.75%5Y: 0.00%10Y: 0.00%
ROIV - Net Income
14-Day FREE Trial Get Full Access Now!
ROIV Net Income CAGR:1Y: -96.68%2Y: 56.21%5Y: 0.00%10Y: 0.00%
ROIV - EBITDA
14-Day FREE Trial Get Full Access Now!
ROIV EBITDA CAGR:1Y: -11.73%2Y: 11.41%5Y: 0.00%10Y: 0.00%
ROIV - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
ROIV Free Cash Flow CAGR:1Y: -0.82%2Y: -3.19%5Y: 0.00%10Y: 0.00%
ROIV - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
ROIV Free Cash Flow / Share CAGR:1Y: 9.87%2Y: -3.83%5Y: 0.00%10Y: 0.00%
ROIV - Gross Profit
14-Day FREE Trial Get Full Access Now!
ROIV Gross Profit CAGR:1Y: -73.83%2Y: -19.35%5Y: 0.00%10Y: 0.00%
ROIV - Expenses
14-Day FREE Trial Get Full Access Now!
ROIV Expenses CAGR:1Y: 414.65%2Y: 89.64%5Y: 0.00%10Y: 0.00%
ROIV - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
ROIV Shares Outstanding CAGR:1Y: -14.42%2Y: 0.66%5Y: 0.00%10Y: 0.00%
ROIV - Share Buybacks
14-Day FREE Trial Get Full Access Now!
ROIV Share Buybacks CAGR:1Y: 0.00%2Y: 1,378.65%5Y: 0.00%10Y: 0.00%
ROIV - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
ROIV Stock-Based Comp CAGR:1Y: 185.96%2Y: 64.04%5Y: 0.00%10Y: 0.00%
ROIV - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
ROIV Revenue CAGR:1Y: -75.72%2Y: -27.28%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ROIV - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ROIV Actual Revenue CAGR:1Y: -75.72%2Y: -27.28%5Y: 0.00%10Y: 0.00%
ROIV - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ROIV Actual EPS CAGR:1Y: -96.19%2Y: 55.75%5Y: 0.00%10Y: 0.00%
ROIV - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ROIV Actual Net Income CAGR:1Y: -96.68%2Y: 56.21%5Y: 0.00%10Y: 0.00%
ROIV - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
ROIV Actual EBITDA CAGR:1Y: -11.73%2Y: 11.41%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ROIV - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
ROIV Net Profit Margin CAGR:1Y: -86.31%2Y: 68.29%5Y: 0.00%10Y: 0.00%
ROIV - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
ROIV Gross Profit Margin CAGR:1Y: 7.78%2Y: 10.90%5Y: 0.00%10Y: 0.00%
ROIV - Price to Earnings
14-Day FREE Trial Get Full Access Now!
ROIV - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
ROIV - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
ROIV - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

Projected Future Returns & Dividends for ROIV

Based on past 4.4-year performance, here are ROIV growth metrics:

Share price CAGR of +2.47%
Dividend CAGR of +0%

Using ROIV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

ROIV (DRIP)ROIV - No DRIP
Current Price$11.58$11.58
Start Shares863.56863.56
Start Value$10,000$10,000
  
After 10 years:
Final Share Count863.56863.56
Dividends Payment$0.00$0.00
Annual Dividends$0$0
Yield on cost0.00%0.00%
Share Price$14.43$11.58
Total Dividends$0$0
Final Value$12,459$10,000

Estimated Future Value + Dividends - ROIV

NOTE: Above numbers are our estimate based on ROIV's Dividend and Price CAGR over past 4.4 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

Roivant Sciences Ltd. (ROIV) had its IPO on , and is trader on NASDAQ stock exchange.

ROIV website: https://roivant.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial